In a recent study posted to the medRxiv* preprint server, researchers reported a method to predict neutralization and protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...

During the current pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (Covid-19), has diversified considerably. As of September ...

In a recent study published on the medRxiv* preprint server, researchers validate a quick, highly efficient, and automated assay to detect neutralizing antibodies (nAb) against the severe acute ...

Biomedical research faces a ubiquitous and fundamental challenge: Because the goal of the research is to improve human health, the human body is logically the best place to perform experiments.

The assays allow scientists to measure neutralizing antibodies quickly and efficiently against wild-type and significant variants of SARS-CoV-2 virus. Scientists developing vaccines and therapeutics ...

Panel A shows mutations in the SARS-CoV-2 spike protein in omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4–BA.5, and BA.4.6. BA.4 and BA.5 are grouped together because they have identical spike ...

When some viruses infect our bodies, “our immune system can create a type of ‘permanent immunity’, meaning that once you’ve been exposed to that virus, you’ve got protection from it and are typically ...